Sripal Bangalore, MD explains the results of the ISCHEMIA-CKD trial, in which researchers compared invasive versus conservative treatment strategies for patients with at least moderate ischemia and advanced chronic kidney disease. Dr. Bangalore is the director of research at the cardiac catheterization lab at NYU Langone Health.

0 Comments